Subscribe to this column
Nagi S. El Saghir, MD, FASCO, FACP
Nagi S. El Saghir, MD, FACP, FASCO, is a professor and director of the Breast Center of Excellence at the American University of Beirut Medical Center (@AUBMC_Official), in Beirut, Lebanon, and head of the Hematology/Oncology Division at the American University of Beirut. He is the founding president of the Lebanese Society of Medical Oncology (LSMO) and has served on several committees within the European Society for Medical Oncology (ESMO). An ASCO member since 1984, Dr. El Saghir is a member of the Journal of Global Oncology editorial board, past chair of the ASCO International Affairs Committee, and co-chair of the Clinical Practice Guidelines Committee's Guidelines Advisory Group for Resource Stratification, as well as a past member of Global Oncology Leadership Task Force and Global Curriculum Committee, among other volunteer roles. Follow Dr. El Saghir on Twitter @NagiSaghir.
Nov 03, 2017
Our recent Patient Empowerment Workshop outlined the importance of screening and early diagnosis in breast cancer, but also emphasized attention and care for women with advanced breast cancer.
Oct 17, 2017
Multidisciplinary units are resouce-intensive, but if you have a computer, you can consult with expert colleagues around the world in a multidisciplinary tumor board.
Jul 24, 2017
Dr. Sana Al-Sukhun, and Dr. Joseph Makdessi, and I share highlights of the Best of ASCO Lebanon meeting, attended by more than 300 health care professionals from the Middle East, Europe, and the United States.
Jul 14, 2017
Drs. Ghassan Abou-Sitta, Imad Kaddoura, and I report on the First International Congress on Conflict Medicine and make recommendations for ensuring that refugee patients with cancer receive adequate, appropriate care.
Apr 07, 2017
My colleagues and I share highlights from a successful and well-publicized breast cancer awareness campaign in Lebanon, focused around International Women's Day.
Feb 17, 2017
BBCC5 offered didactic sessions with presentations on recent advances in breast cancer research and management and 1-hour tumor board sessions where a panel of experts and the audience discuss real cases of patients with breast cancer.
Latest Blogs